KESTRA PRIVATE WEALTH SERVICES, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1649451
AUSTIN, TX
Position in REGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$588,621
-$178,610 QoQ
Shares Held
944
-4.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#767
of 1,322 holders
Holding Since
Mar 2021
22 quarters on record
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KESTRA PRIVATE WEALTH SERVICES, LLC holds $13,960,546 across 25 Biotechnology names. REGN ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,539 | $5,235,037 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
50,588 | $2,379,659 | |
| 3 | INCY |
Incyte Corp
|
8,684 | $984,418 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,753 | $748,300 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
944 | $588,621 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
10,555 | $575,669 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
13,064 | $509,626 | |
| 8 | RPRX |
Royalty Pharma plc
|
7,881 | $441,887 |
All Filings in REGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $588,621 | 944 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $767,231 | 993 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $806,604 | 1,045 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $592,632 | 1,054 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $845,775 | 1,611 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,305,245 | 2,058 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,371,947 | 1,926 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,793,415 | 1,706 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,445,166 | 1,375 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,686,282 | 1,752 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,556,329 | 1,772 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,217,980 | 1,480 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $990,148 | 1,378 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,034,482 | 1,259 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $656,555 | 910 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $336,857 | 489 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $416,746 | 705 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $623,689 | 893 | Shares | Sole | 2022-07-21 | |
| 2021-12-31 | $685,830 | 1,086 | Shares | Sole | 2022-07-21 | |
| 2021-09-30 | $381,263 | 630 | Shares | Sole | 2022-07-26 | |
| 2021-06-30 | $342,943 | 614 | Shares | Sole | 2022-07-27 | |
| 2021-03-31 | $314,164 | 664 | Shares | Sole | 2022-07-27 | |
| No filing history on record for this holder in this stock. | ||||||